Novel Therapeutic Approach to Improve Hematopoiesis in low risk MDS by Targeting MDSCs with The Fc-engineered CD33 Antibody BI 836858

We recently reported that the accumulation of myeloid-derived suppressor cells (MDSC), defined as CD33(+)HLA-DR(−)Lin(−), plays a direct role in the pathogenesis of myelodysplastic syndrome (MDS). In particular, CD33 is strongly expressed in MDSC isolated from patients with MDS where it plays an imp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Leukemia
Autores principales: Eksioglu, Erika A., Chen, Xianghong, Heider, Karl-Heinz, Rueter, Bjoern, McGraw, Kathy L., Basiorka, Ashley A., Wei, Max, Burnette, Alexis, Cheng, Pinyang, Lancet, Jeffrey, Komrokji, Rami, Djeu, Julie, List, Alan, Wei, Sheng
Formato: Artigo
Lenguaje:Inglês
Publicado: 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5552472/
https://ncbi.nlm.nih.gov/pubmed/28096534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2017.21
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares